Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — National Healthcare Properties, Inc.

Accession: 0001561032-26-000071

Filed: 2026-11-04

Period: 2026-11-04

CIK: 0001561032

SIC: 6798 (REAL ESTATE INVESTMENT TRUSTS)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — hct-20261104.htm (Primary)

GRAPHIC (a6098_nhpxlogoxcmykxfinal.jpg)

EX-99.1 (q32026earningspressrelease.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: hct-20261104.htm · Sequence: 1

hct-20261104

FALSE000156103200015610322026-11-042026-11-040001561032us-gaap:CommonClassAMember2026-11-042026-11-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 4, 2026

National Healthcare Properties, Inc.

(Exact Name of Registrant as Specified in Charter)

Maryland 001-39153 38-3888962

(State or other jurisdiction

of incorporation) (Commission File Number) (I.R.S. Employer

Identification No.)

540 Madison Ave., 27th Floor

New York, NY 10022

__________________________________________________________________________________________________________________________________________________________________________

(Address, including zip code, of Principal Executive Offices)

Registrant’s telephone number, including area code: (332) 258-8770

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Common stock, $0.01 par value per share NHP The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02. Results of Operations and Financial Condition.

National Healthcare Properties, Inc. (the “Company”) issued a press release on November 4, 2026 announcing its financial results for the quarter ended September 30, 2026. A copy of the press release is furnished herewith and attached hereto as Exhibit 99.1. The information in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act except as set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1

Press Release of National Healthcare Properties, Inc. dated November 4, 2026

104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NATIONAL HEALTHCARE PROPERTIES, INC.

Date: November 4, 2026

By:

/s/ Andrew T. Babin

Andrew T. Babin

Chief Financial Officer and Treasurer

GRAPHIC

GRAPHIC

Filename: a6098_nhpxlogoxcmykxfinal.jpg · Sequence: 6

Binary file (782052 bytes)

Download a6098_nhpxlogoxcmykxfinal.jpg

EX-99.1

EX-99.1

Filename: q32026earningspressrelease.htm · Sequence: 7

Q3 2026 Earnings Press Release

National Healthcare Properties Reports Third Quarter 2026 Results

— SHOP Same Store Cash NOI increased 13.6% year-over-year —

— $664 million of 2026 SHOP acquisitions completed or under definitive agreement —

—SHOP Same Store Cash NOI growth guidance increased by 100bps at its mid-point —

NEW YORK, November 4, 2026 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHP)

(the “Company”), a self-managed real estate investment trust focused on providing needs-based senior housing to

serve a growing elderly population in the United States, today announced results for the quarter ended

September 30, 2026.

Michael Anderson, Chief Executive Officer and President, commented, “2026 continues to be a transformational

year for the Company, and the third quarter included important milestones in our pursuit of a SHOP-only portfolio

and an investment grade balance sheet. During the quarter, we succeeded in strategically increasing our same-store

SHOP occupancy to improve our operating position into the fourth quarter, closed on more than $300 million of

SHOP acquisitions at attractive yields, and utilized proceeds from our new unsecured term loan and the first tranche

of our OMF exit to significantly reduce our secured debt. We enter the fourth quarter with a stronger platform and

clear momentum, focused on delivering long-term value for our shareholders”

Financial Performance and Recent Highlights

•Net income attributable to common stockholders of $0.24 per basic and diluted share. Nareit defined Funds

From Operations (“FFO”) of $0.13 per diluted share and Normalized Funds From Operations (“Normalized

FFO”) of $0.19 per diluted share.

•FFO per share decreased 43.5% year-over-year.

•Normalized FFO per share decreased 29.6% year-over-year.

•Third quarter portfolio Same Store Cash Net Operating Income (“NOI”) growth was 8.4% year-over-year.

Senior Housing Operating Portfolio (“SHOP”) Segment:

•Same Store Cash NOI growth was 13.6% year-over-year.

•Same Store average occupancy totaled 86.7%, an increase of 2.2%  year-over-year.

•Same Store RevPOR increased 4.0% year-over-year.

•Same Store Cash NOI Margin of 24.3%, an expansion of 1.5% year-over-year.

Outpatient Medical Facility (“OMF”) Segment:

•Same Store Cash NOI decreased by 0.3% year-over-year.

•Same Store ending occupancy totaled 95.6%, an increase of 0.2% year-over-year.

Transactional Activity

Acquisitions and Pipeline

During the third quarter, the Company acquired 22 SHOP communities, consisting of 1,381 units, for a total

purchase price of $300 million. These acquisitions introduced a new operator relationship with Priority Life Care,

which manages three of the communities. The remaining 19 communities are managed by the Company’s existing

operating partners. Subsequent to the third quarter, the Company acquired one SHOP community, consisting of 79

units, for a purchase price of $26 million. This community is managed by one of the Company's existing operating

partners. Year-to-date, the Company has acquired 25 SHOP communities for approximately $424 million.

The Company currently has signed purchase and sale agreements for approximately $240 million of SHOP

acquisitions with estimated weighted average year-one and year-three cap rates of approximately 7.4% and 8.7%,

respectively, and an additional approximately $148 million of SHOP acquisitions under non-binding letters of intent.

These acquisitions total approximately $388 million and comprise 1,385 primarily assisted living and memory care

units. Closing of these acquisitions is subject to continued purchaser due diligence, closing conditions and regulatory

approvals as specified in the applicable agreements, and, for acquisitions under non-binding letters of intent, the

negotiation and execution of definitive agreements.

Non-Core SHOP Dispositions

In August 2026, the Company completed the sale of one non-core SHOP community in California for approximately

$42 million.

In September 2026, the Company entered into a definitive purchase and sale agreement to sell one non-core SHOP

community in Michigan for approximately $9 million.

OMF Dispositions

The Company previously announced the sale of 86 OMFs for approximately $528 million. In September 2026, the

Company completed the sale of the first 30 OMFs in this portfolio for approximately $198 million. In connection

with the sale, the Company repaid in full its Secured Term Loan 1 due 2028 and Secured Term Loan 3 due 2031,

totaling $119 million. The remaining 56 OMFs in this portfolio are subject to a $219 million loan assumption and

are expected to close in Q4 2026 for $331 million. The Company also entered into a definitive purchase and sale

agreement to sell an additional 40 OMFs for approximately $531 million (before transaction expenses, property

operating prorations and capital expenditure and other adjustments), and signed a non-binding letter of intent to sell

its remaining four OMFs. Inclusive of these transactions, the Company expects to fully exit the OMF segment.

There can be no assurance that these pending transactions will close on the terms described, or at all.

Balance Sheet and Capital

As of September 30, 2026, total debt outstanding (net of discounts and unamortized debt issuance costs) was

approximately $851.2 million with a weighted average economic interest rate of 5.12% (when giving effect to

interest rate hedges and caps) and an average remaining term of 4.9 years.

Net Leverage (Net Debt as of September 30, 2026 to Annualized Adjusted EBITDA for the quarter ended

September 30, 2026) improved by 3.3x to 5.5x as of September 30, 2026 from 8.8x as of September 30, 2025.

In August 2026, the Company amended and restated its senior unsecured credit facilities, which provide for, among

other things, (i) an increase in total lender commitments from $550 million to $1.2 billion, with the revolving facility

increasing from $400 million to $750 million, the term loan increasing from $150 million to $300 million and a new

$150 million delayed draw term loan facility being added, (ii) an extension of the maturity of the revolving facility

and the term loan (including the delayed draw term loan) to August 2030 and August 2029, respectively, each with

extension options that, if fully exercised, would extend the final maturity to August 2031, and (iii) a reduction in the

applicable margins for interest rates based on the Company's corporate leverage ratio. In connection with the credit

facilities recast, the Company repaid the $332 million outstanding under its Fannie Mae secured debt due to mature

in November 2026.

Credit Facilities

Prior

Current

Total Facility

$550 million

$1.2 billion

Accordion

$450 million

$1 billion

Unused Fee

15 to 20 bps

N/A

Revolver

Spread

SOFR + 155 to 210 bps

SOFR + 105 to 155 bps

Facility Fee

N/A

15 to 35 bps

Capacity

$400 million

$750 million

Term Loans

Spread

SOFR + 155 to 210 bps

SOFR + 110 to 180 bps

Capacity

$150 million

$300 million + $150 million Delayed Draw

Common and Preferred Stock

Common Stock

On July 1, 2026, the Board of Directors declared a quarterly dividend of $0.075 per share of its common stock

(including its Class A Common Stock). The dividend was paid in cash on July 30, 2026 to holders of record as of the

close of business on July 15, 2026.

On October 1, 2026, the Board of Directors declared a quarterly dividend of $0.075 per share of its common stock.

The dividend was paid in cash on October 16, 2026 to holders of record as of the close of business on October 12,

2026.

On October 19, 2026, all outstanding shares of the Company's Class A common stock converted into the Company's

common stock on a one-for-one basis. All shares of common stock became freely tradable on the Nasdaq Global

Market on this date. The conversion had no impact on the economic rights of shareholders of shares of Class A

common stock and the Company's operations.

Preferred Stock

On September 4, 2026, the Company redeemed all 3,289,061 outstanding shares of its 7.375% Series A Cumulative

Redeemable Perpetual Preferred Stock.

On October 6, 2026, the Company redeemed all 2,850,427 outstanding shares of its 7.125% Series B Cumulative

Redeemable Perpetual Preferred Stock.

Each redemption was at $25.00 per share plus accrued and unpaid dividends thereon to, but not including each

redemption date. As a result of the redemptions, the Company expects to save approximately $11 million in annual

preferred dividends.

Revised Full Year 2026 Guidance

For the full year 2026, the Company is revising certain guidance ranges as follows:

As of 8/5/26

As of 11/4/26

SHOP Same Store Cash NOI growth

15.0% to 18.0%

16.5% to 18.5%

OMF Same Store Cash NOI growth

2.5% to 3.5%

—

Acquisitions

$375 million to $425 million

$425 million to $645 million

Dispositions

$570 million

$1.1 billion

General and administrative expense,

including equity-based compensation

$27 million to $28 million

$27 million to $28 million

Equity-based compensation

$6 million to $7 million

$6 million to $7 million

Same Store Recurring Capital Expenditures

$22 million to $25 million

—

Same Store SHOP Recurring Capital

Expenditures

—

$10 million to $11 million

Total OMF Portfolio Recurring Capital

Expenditures

—

$7 million to $8 million

Full Year 2026 Guidance Commentary

The revision in the Company’s guidance is primarily the result of SHOP segment outperformance through the

current quarter as well as expectations for the remainder of the year, SHOP acquisitions expected to close during the

year, the ongoing and expected disposition of the OMF portfolio and  a non-core SHOP asset.

Note: The Company’s 2026 guidance contains forward-looking statements and is based on a number of assumptions

and estimates, including those identified later in this press release. These assumptions and estimates are based on

existing market conditions, transaction timing and other assumptions for the year ending December 31, 2026; actual

results may differ materially.

Supplemental Information

Additional information regarding these results can be found in the Company’s supplemental financial package that

will be available on the Investor Relations section of the Company’s website at nhpreit.com.

About National Healthcare Properties

National Healthcare Properties, Inc. (Nasdaq: NHP) is a self-managed real estate investment trust focused on

providing needs-based senior housing to serve a growing elderly population in the United States. Additional

information about the Company can be found on its website at nhpreit.com.

Investor & Media Contact

Email: ir@nhpreit.com

Forward-Looking Statements

This press release may contain “forward-looking” statements as defined in the Private Securities Litigation Reform

Act of 1995. All statements (other than statements of historical fact) in this press release regarding the Company's

prospects, expectations, intentions, plans, financial position, guidance and business strategy may constitute forward-

looking statements. Forward-looking statements generally can be identified by the use of terminology such as

“believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “should,” “predict,” “project,”

“potential,” “continue” or the negatives of these terms or variations of them or similar expressions. Risks and

uncertainties, the occurrence of which could adversely affect the Company's business and cause actual results to

differ materially from those expressed or implied in the forward-looking statements, include, but are not limited to,

the following: changes in economic cycles generally and in the real estate and healthcare markets specifically; the

success of the Company's growth strategy, including its ability to successfully identify, complete and integrate new

acquisitions; the Company’s ability to complete acquisitions or dispositions on the terms and timing the Company

expects, or at all; changes to inflation and interest rates; competition in the real estate and healthcare markets; the

Company's ability to retain certain key personnel; legislative and regulatory changes in the healthcare and real estate

industries; reductions or changes in reimbursement from third-party payors, including Medicare and Medicaid;

discovery of previously undetected environmentally hazardous conditions; the Company's ability to pay down,

refinance, restructure or extend its indebtedness as it becomes due; system failures, cyber incidents or deficiencies in

the Company's cybersecurity systems; the availability of capital on favorable terms, or at all; the Company's ability

to remain qualified as a real estate investment trust for U.S. federal income tax purposes; and other risks and

uncertainties described in the section titled Risk Factors of the Company's most recent Annual Report on Form 10-K

and all other filings with the Securities and Exchange Commission. Cap rates for the Company's acquisition pipeline

included in this press release are calculated by dividing the underwritten cash NOI that the Company aims to achieve

(some of which are based on preliminary information provided by sellers and certain assumptions applied by the

Company) by the total aggregate purchase price, not including certain initial acquisition capital expenditures. The

actual stabilized cash NOI yields from the Company’s pipeline may not be consistent with the targeted stabilized

cash NOI yield range. Finally, the Company assumes no obligation to update or revise any forward-looking

statements or to update the reasons why actual results could differ from those projected in any forward-looking

statements.

Financial Statements and Definitions

This press release includes certain non-GAAP financial measures, including Nareit FFO, Normalized FFO, Net

Debt, EBITDA, Adjusted EBITDA, NOI, Cash NOI and Same Store Cash NOI. While the Company believes that

non-GAAP financial measures are helpful in evaluating its operating performance, the use of non-GAAP financial

measures in this press release should not be considered in isolation from, or as an alternative for, a measure of

financial or operating performance as defined by GAAP. There are inherent limitations associated with the use of

each of these supplemental non-GAAP financial measures as an analytical tool. Additionally, the Company’s

computation of non-GAAP financial measures may not be comparable to those reported by other REITs. Definitions

of these non-GAAP financial measures and reconciliations to their most directly comparable GAAP measures are

provided below.

Nareit FFO and Normalized FFO

The Company calculates FFO consistent with the standards established over time by Nareit. Nareit defines FFO as

net income or loss (computed in accordance with GAAP), adjusted for (i) real estate-related depreciation and

amortization, (ii) impairment charges on depreciable real property, (iii) gains or losses from sales of depreciable real

property and (iv) similar adjustments for non-controlling interests and unconsolidated entities.

The Company calculates Normalized FFO by further adjusting FFO to reflect the performance of its portfolio for

items it believes are not directly attributable to its operations. The Company's adjustments to FFO to arrive at

Normalized FFO include removing the impacts of (i) acquisition and transaction related costs; (ii) termination fees

to related parties; (iii) severance and other related costs; (iv) mark-to-market gains and losses on non-designated

derivatives and amortization related to terminated derivatives; (v) casualty-related charges, net relating to

significantly disruptive events that are infrequent in nature; (vi) gains and losses on extinguishment of debt; (vii)

similar adjustments for non-controlling interests; and (viii) certain other items set forth in the Normalized FFO

reconciliation included therein.

The Company considers FFO and Normalized FFO to be useful supplemental measures for reviewing comparative

operating and financial performance because, by excluding the applicable items listed above, FFO and Normalized

FFO can help investors compare the Company's operating performance between periods or to other companies

(though other companies may calculate these measures differently than the Company does and the value of any such

comparison may be limited). While FFO and Normalized FFO are relevant and widely used measures of operating

performance of REITs, they do not represent, nor are they meant to replace, cash flows from operations and net

income or loss as defined by GAAP, and should not be considered alternatives to those measures in evaluating the

Company's liquidity or operating performance. Rather, FFO and Normalized FFO should be reviewed in conjunction

with these and other GAAP measurements as an indication of the Company's operational performance and are not

necessarily indicative of cash available to fund the Company's future cash requirements, including the Company's

ability to pay dividends and other distributions to the Company's stockholders. Additionally, the Company's

computation of FFO and Normalized FFO may not be comparable to FFO and Normalized FFO reported by other

REITs that do not define FFO in accordance with the current National Association of Real Estate Investment Trusts

(“NAREIT”) definition or that interpret the current NAREIT definition or define Normalized FFO differently than

the Company does.

Adjusted EBITDA

The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, excluding

(i) acquisition and transaction related costs; (ii) termination fees to related parties; (iii) impairment charges; (iv)

casualty-related charges; (v) gains and losses on sale of real estate investments; (vi) gains and losses on

extinguishment of debt; (vii) gains and losses on our derivatives; and (viii) non-cash items such as amortization of

intangibles and equity-based compensation. Annualized Adjusted EBITDA means Adjusted EBITDA for the

specified quarter, multiplied by four.

Cash NOI and NOI

Cash NOI is defined as NOI excluding non-cash items such as straight-line rent adjustments and amortization of

above and below market lease and lease intangibles that are included in GAAP revenue from tenants and property

operating and maintenance.

Cash NOI Margin

For the SHOP segment, Cash NOI divided by revenue from tenants or residents excluding net amortization of

above- and below-market lease and lease intangibles.

Net Debt

Net debt means total debt, net of deferred financing costs, mortgage discounts and premiums less cash and cash

equivalents.

Net Debt to Annualized Adjusted EBITDA or Net Leverage

Net Debt to Annualized Adjusted EBITDA or Net Leverage means Net Debt divided by Annualized Adjusted

EBITDA.

Non-Core Properties

Non-Core properties are  assets that have been deemed not essential to generating future economic benefit or value

to our day-to-day operations and/or are scheduled to be sold with closing conditions substantially fulfilled.

Leased % or Ending occupancy

Leased % or Ending occupancy for the OMF segment is presented as of the end of the period shown.

Recurring Capital Expenditures

Recurring Capital Expenditures means capital expenditures incurred to maintain the properties in current market

condition and which are generally recurring in nature.

Same Store

Same Store means operational properties owned by the Company for the full duration of the applicable comparative

periods and that are not otherwise excluded. Properties are excluded from “same store” if they are (i) Non-Core

Properties, (ii) sold, classified as held for sale, or classified as discontinued operations in accordance with GAAP,

(iii) impacted by materially disruptive events, or (iv) undergoing, or intended to undergo, significant redevelopment.

Redeveloped properties in our OMF segment will be included in Same Store once substantial completion of work

has occurred for the full period in the periods presented.

Same Store Cash NOI

Same Store Cash NOI is defined as Cash NOI for our Same Store properties.

NATIONAL HEALTHCARE PROPERTIES, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)

September 30, 2026

December 31, 2025

ASSETS

Real estate investments, at cost:

Land

$168,716

$174,535

Buildings, fixtures and improvements

1,893,128

1,785,952

Acquired intangible assets

235,245

246,544

Construction in progress

4,889

2,994

Total real estate investments, at cost

2,301,978

2,210,025

Less: accumulated depreciation and amortization

(627,462)

(691,200)

Total real estate investments, net

1,674,516

1,518,825

Cash and cash equivalents

125,069

57,620

Restricted cash

18,966

50,832

Derivative assets, at fair value

9,936

569

Straight-line rent receivable, net

18,048

21,486

Operating lease right-of-use assets

13,941

7,377

Prepaid expenses and other assets, net

25,798

23,019

Accounts receivable, net

9,702

9,252

Deferred costs, net

18,839

22,792

Total assets

$1,914,815

$1,711,772

LIABILITIES AND EQUITY

Liabilities

Mortgage notes payable, net

$249,581

$367,629

Fannie Mae secured debt

—

334,739

Revolving credit facility

305,000

186,000

Term loan, net

296,661

148,405

Market lease intangible liabilities, net

4,002

4,851

Derivative liabilities, at fair value

—

188

Accounts payable and accrued expenses

121,053

44,381

Operating lease liabilities

8,205

8,467

Deferred rent

7,898

9,247

Distributions payable

1,340

3,340

Total liabilities

993,740

1,107,247

Commitments and contingencies

Equity

7.375% Series A cumulative redeemable perpetual preferred stock, $0.01 par

value, — authorized

—

38

7.125% Series B cumulative redeemable perpetual preferred stock, $0.01 par

value, 2,900 authorized

—

35

Common stock, $0.01 par value, 300,000 shares authorized

1,132

1,132

Class A common stock, $0.01 par value, 100,0000 shares authorized

443

—

Additional paid-in capital

2,849,755

2,531,315

Accumulated other comprehensive income

8,420

5,604

Distributions in excess of accumulated earnings

(1,941,567)

(1,938,060)

Total stockholders’ equity

918,183

600,064

Non-controlling interests

2,892

4,461

Total equity

921,075

604,525

Total liabilities and equity

$1,914,815

$1,711,772

NATIONAL HEALTHCARE PROPERTIES, INC.

CONSOLIDATED INCOME STATEMENTS

(In thousands, except per share data)

(Unaudited)

Three months ended September 30,

Nine months ended September 30,

2026

2025

2026

2025

Revenue from tenants

$103,062

$86,026

$276,877

$257,801

Operating expenses:

Property operating and maintenance

69,576

53,845

176,613

165,880

Impairment charges

6,874

6,641

10,654

33,752

Acquisition and transaction related

875

91

1,058

639

General and administrative

7,806

5,671

19,877

15,642

Depreciation and amortization

24,417

18,029

59,966

60,274

Total expenses

109,548

84,277

268,168

276,187

Operating (loss) income before gain on sale of

real estate investments

(6,486)

1,749

8,709

(18,386)

Gain on sale of real estate investments

38,298

626

38,296

28,267

Operating income

31,812

2,375

47,005

9,881

Other income (expense):

Interest expense

(12,159)

(15,060)

(39,553)

(45,425)

Interest and other income, net

981

294

3,497

512

(Loss) gain on extinguishment of debt

(427)

—

(427)

257

(Loss) gain on non-designated derivatives

(64)

(77)

78

(46)

Total other expense, net

(11,669)

(14,843)

(36,405)

(44,702)

Income (loss) before income taxes

20,143

(12,468)

10,600

(34,821)

Income tax (expense) benefit

97

(66)

(27)

(60)

Net income (loss)

20,240

(12,534)

10,573

(34,881)

Net income attributable to non-controlling

interests

(61)

(21)

(59)

(44)

Allocation for preferred stock

(2,401)

(3,326)

(8,480)

(10,162)

Net income (loss) attributable to common

stockholders

17,778

(15,881)

2,034

(45,087)

Other comprehensive income (loss):

Unrealized income (loss) on designated

derivatives

3,610

(1,881)

2,816

(9,080)

Comprehensive income (loss) attributable to

common stockholders

$21,388

$(17,762)

$4,850

$(54,167)

Weighted-average shares outstanding (1)

Basic

72,645

28,297

54,347

28,297

Diluted

73,234

28,549

54,754

28,536

Net income (loss) per share attributable to common

stockholders (1)

Basic

$0.24

$(0.56)

$0.04

$(1.59)

Diluted

$0.24

$(0.56)

$0.04

$(1.59)

(1)  Potential common shares are not included in the computation of diluted earnings per share (“EPS”) when a net loss

exists as the effect would be an antidilutive per share amount.

NATIONAL HEALTHCARE PROPERTIES, INC.

NON-GAAP FINANCIAL MEASURES RECONCILIATION

(In thousands, except per share data)

(Unaudited)

Three months ended

Q3 2026

Q3 2025

Net income (loss) attributable to common stockholders

$17,778

$(15,881)

Adjustments:

Impairment charges

6,874

6,641

Acquisition and transaction related

875

91

General and administrative

7,806

5,671

Depreciation and amortization

24,417

18,029

Gain on sale of real estate investments

(38,298)

(626)

Interest expense

12,159

15,060

Interest and other income, net

(981)

(294)

Loss on extinguishment of debt

427

—

Loss on non-designated derivatives

64

77

Income tax (benefit) expense

(97)

66

Net income attributable to non-controlling interests

61

21

Allocation for preferred stock

2,401

3,326

NOI

$33,486

$32,181

NOI by Segment

OMF

$15,436

$20,631

SHOP

18,050

11,550

Total NOI

$33,486

$32,181

(1)Certain 2025 amounts have been reclassified from general and administrative to property operating and maintenance

to align with the current period presentation.

NATIONAL HEALTHCARE PROPERTIES, INC.

NON-GAAP FINANCIAL MEASURES RECONCILIATION

(In thousands, except per share data)

(Unaudited)

Three months ended

Q3 2026

Q3 2025

Net income (loss) attributable to common stockholders

$17,778

$(15,881)

Depreciation and amortization on real estate assets

22,856

16,647

Impairment charges

6,874

6,641

Gain on sale of real estate

(38,298)

(626)

Depreciation on real estate assets related to non-controlling interests

—

(73)

FFO attributable to common stockholders

9,210

6,708

Acquisition and transaction related

875

91

Derivatives mark-to-market and terminations (1)

(1,105)

911

Casualty-related charges, net

58

115

Loss on extinguishment of debt

427

—

Normalizing items related to non-controlling interests

(27)

(10)

Other normalizing items, net (2)

4,209

—

Normalized FFO attributable to common stockholders

$13,647

$7,815

FFO and Normalized FFO weighted average shares outstanding — Diluted (3)

73,234

28,549

FFO per common share — Diluted

$0.13

$0.23

Normalized FFO per common share — Diluted

$0.19

$0.27

Other Items:

(Accretion) amortization of market lease and other intangibles, net

$(139)

$(174)

Straight-line rent adjustments

(387)

(753)

Equity-based compensation

2,134

1,333

Depreciation and amortization on non-real estate assets

1,562

1,382

Amortization of deferred financing costs and mortgage discounts or premiums

1,032

761

Recurring Capital Expenditures

(4,019)

(4,452)

(1) For Q3 2026, includes $1.4 million of amortization reclassified from OCI to earnings (reduced interest expense)

from a swap termination.

(2) Includes $4.3 million of straight-line rent written off in connection with the sale of 30 OMFs in September 2026.

(3) For Q3 2026, reflects 73,264 common shares and dilutive equity awards and units outstanding as of September 30,

2026, including 355 unvested share-based awards and 234 Common OP units.

NATIONAL HEALTHCARE PROPERTIES, INC.

NON-GAAP FINANCIAL MEASURES RECONCILIATION

(In thousands, except per share data)

(Unaudited)

Three months ended

Q3 2026

Q2 2026

Q1 2026

Q4 2025

Q3 2025

Net income (loss) (in accordance with GAAP)

$20,240

$(5,386)

$(4,281)

$(22,802)

$(12,534)

Interest expense

12,159

12,723

14,671

15,856

15,060

Income tax (benefit) expense

(97)

47

77

101

66

Depreciation and amortization

24,417

17,811

17,738

17,987

18,029

EBITDA

56,719

25,195

28,205

11,142

20,621

Acquisition and transaction related

875

130

53

(123)

91

Equity-based compensation

2,134

1,614

612

682

1,333

Severance and related costs (1)

—

—

—

2,907

—

Impairment charges

6,874

3,780

—

11,162

6,641

(Gain) loss on sale of real estate investments

(38,298)

—

2

467

(626)

Loss (gain) on non-designated derivatives

64

47

(189)

26

77

Loss on extinguishment of debt

427

—

—

—

—

Accretion of market lease and other intangibles, net

(139)

(147)

(147)

(165)

(174)

Casualty-related charges, net

58

7

142

627

115

Other normalizing items, net (2)

4,209

21

—

—

—

Adjusted EBITDA

32,923

30,647

28,678

26,725

28,078

Adjustment for current period activity

(364)

1,980

13

429

Further Adjusted EBITDA

$32,559

$32,627

$28,691

$27,154

Net Leverage (Net debt / Annualized Adjusted

EBITDA)

5.5x

4.9x

8.6x

9.2x

8.8x

Net debt / Annualized Further Adjusted EBITDA

5.6x

4.6x

8.6x

9.0x

(1) Represents cash severance, acceleration of equity vesting and other related expenses in connection with the transition

of the chief financial officer role in 2025.

(2) Includes $4.3 million of straight-line rent written off in connection with the sale of 30 OMFs in September 2026.

NATIONAL HEALTHCARE PROPERTIES, INC.

NON-GAAP FINANCIAL MEASURES RECONCILIATION

(In thousands, except share, per share and property data)

(Unaudited)

Three months ended

Q3 2026

Q3 2025

OMF Segment

OMF segment - revenue from tenants

$22,341

$29,022

OMF segment - property operating and maintenance

(6,905)

(8,391)

OMF segment NOI

15,436

20,631

Straight line rent adjustments (1)

3,878

(754)

(Accretion) amortization of market lease and other intangibles, net

(145)

(164)

OMF segment Cash NOI

19,169

19,713

Dispositions

(2,485)

(3,420)

Non-Core properties (2)

(9,488)

(9,075)

OMF segment Same Store Cash NOI

$7,196

$7,218

(1) Includes $4.3 million of straight-line rent written off in connection with the sale of 30 OMFs in September 2026.

(2) Includes a redevelopment property that is under a definitive purchase and sale agreement.

Three months ended

Q3 2026

Q3 2025

SHOP Segment

SHOP segment - revenue from tenants

$80,721

$57,004

SHOP segment - property operating and maintenance

(62,671)

(45,454)

SHOP segment NOI

18,050

11,550

Non-cash adjustments

6

(9)

SHOP segment Cash NOI

18,056

11,541

Acquisitions

(5,471)

—

Dispositions

441

329

Non-Core properties

489

22

SHOP segment Same Store Cash NOI

$13,515

$11,892

OMF

SHOP

Land

Total

Total properties as of June 30, 2026

130

39

1

170

Acquisitions

—

22

—

22

Dispositions

(30)

(1)

—

(31)

Total properties as of September 30, 2026

100

60

1

161

Non-Core properties

(40)

(1)

—

(41)

Acquisitions

—

(24)

—

(24)

Same Store properties as of September 30, 2026

60

35

1

96

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.3

Cover Page

Nov. 04, 2026

Document Information [Line Items]

Document Type

8-K

Document Period End Date

Nov. 04, 2026

Entity Registrant Name

National Healthcare Properties, Inc.

Entity Incorporation, State or Country Code

MD

Entity File Number

001-39153

Entity Tax Identification Number

38-3888962

Entity Address, Address Line One

540 Madison Ave.

Entity Address, Address Line Two

27th Floor

Entity Address, City or Town

New York

Entity Address, State or Province

NY

Entity Address, Postal Zip Code

10022

City Area Code

332

Local Phone Number

258-8770

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Amendment Flag

false

Entity Central Index Key

0001561032

Common Class A

Document Information [Line Items]

Title of 12(b) Security

Common stock, $0.01 par value per share

Trading Symbol

NHP

Security Exchange Name

NASDAQ

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_DocumentInformationLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type: